Brainstorm Seminar Series II
Laurie H. Glimcher, M.D.
President and CEO, Dana-Farber Cancer Institute
Richard and Susan Smith Professor of Medicine, Harvard Medical School
《The Future of Immunotherapy: Reprogramming the Tumor Microenvironment》
Wenru Song, M.D., Ph.D.
Co-Founder, President and Board Chair, Kira Pharmaceuticals.
Former Global VP, Immuno-Oncology Development at AstraZeneca.
《Cancer Immunotherapy: Unique Clinical Development Considerations》
Nancy Simonian, M.D.
CEO, Syros Pharmaceuticals
Former CMO, Millennium Pharmaceuticals
Vice President, Clinical Development at Biogen
《Targeting Non-coding Region for Cancer Therapy》